Compounded Tirzepatide Cost: What Drives the Price and What It Covers
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Compounded tirzepatide is not the same as brand-name products such as Zepbound or Mounjaro and may differ in formulation, purity, and potency.
You have been researching compounded tirzepatide, and the price variation online is confusing. Some programs advertise one number, others charge much more. Some mention labs, some do not. Here is what drives the cost of compounded tirzepatide, what a monthly fee may or may not include, and how to compare programs on total cost.
What to check before using compounded tirzepatide
Transformation Health does not sell medication or set prices. Prices vary by program and dose. We plan to publish current market prices with sources and capture dates; until then, use the factors below to compare what programs quote you.
- Dose tier. Tirzepatide is usually started at a low dose and stepped up over the first months. Many programs charge more at higher doses, so a starting-dose price is not the price you will pay at a maintenance dose.
- Flat vs per-dose pricing. Some programs charge one flat monthly price at every dose. Others price each dose tier separately. Ask which model the program uses and what the price is at each step.
- What the fee includes. Some fees bundle medication, provider visits, and follow-up. Others cover the medication only.
- Lab work. Some programs include required labs; others bill them separately or ask you to get them through your own provider.
- Shipping and supplies. Check whether shipping, syringes, alcohol pads, and sharps containers are included.
- Add-on fees and cancellation terms. Look for separate membership or consultation fees, minimum commitments, prepay requirements, and how cancellation works.
Compare the total cost: medication at your likely dose, dose increases, visits, labs, shipping, membership fees, and cancellation terms.
What is included (and what is not)
There is no standard bundle. When you compare programs, look for each of these line items and note whether it is included, billed separately, or not offered.
The medication. Compounded tirzepatide is prepared by a state-licensed compounding pharmacy and, at most telehealth programs, shipped to you with supplies for self-injection. Tirzepatide is usually injected once weekly. Ask which pharmacy prepares it.
Lab work. Some programs require blood work before or during treatment. Ask whether it is included, where it is drawn, and whether it is billed to you or your insurance.
Provider care. At most telehealth programs, a licensed provider reviews your health history and current medications, decides whether a prescription is appropriate, and follows up during treatment. Ask whether follow-up visits cost extra.
Coaching or nutrition support. Some programs include nutrition or lifestyle coaching; many do not. If it matters to you, ask what it involves and whether it costs extra.
What is usually not included. Telehealth programs generally do not cover other healthcare services, such as primary care or specialist visits. If a provider decides you need additional evaluation before starting, that visit is usually billed separately.
Transformation Health does not accept payment from providers. How we make money.
Regulatory status and compounding availability
Compounded tirzepatide exists within a specific legal framework, and its status has changed.
Shortage status. On December 19, 2024, after re-evaluating its earlier decision, the FDA reissued its determination that the tirzepatide injection shortage was resolved[1]. While a drug is on the shortage list, compounders have more room to prepare copies of it.
What FDA said about compounders. After a March 5, 2025 court decision denied a preliminary injunction in Outsourcing Facilities Association v. FDA, the FDA stated that its enforcement discretion period for state-licensed 503A pharmacies compounding tirzepatide injection had ended. For 503B outsourcing facilities, that period ran until March 19, 2025[1]. The FDA page has later updates, most recently dated April 1, 2026; check it for the current statement[1].
What this means for you. Compounded tirzepatide is still offered by some telehealth programs, but availability depends on federal and state law and FDA action, and it can change. If you are planning longer-term treatment, ask the provider you choose what would happen if the compounded option became unavailable, and what brand-name options (through insurance or manufacturer programs) would cost you.
Brand-name tirzepatide pricing for comparison
Brand-name tirzepatide is FDA-approved and sold as Zepbound (for chronic weight management, and for moderate to severe obstructive sleep apnea in adults with obesity) and Mounjaro (for type 2 diabetes)[2][3]. Paid out of pocket, it generally costs more than compounded tirzepatide. Manufacturer self-pay programs and insurance coverage can change what you pay. We plan to publish current brand-name self-pay prices from the manufacturer’s own pages, with capture dates.
If you have insurance, coverage for weight management medications is inconsistent. Many plans exclude weight loss medications, and plans that cover them often require prior authorization, which can take time.
A lower price for compounded tirzepatide reflects the different production model, not clinical equivalence. Compounded tirzepatide is not FDA-approved and is not the same product as Zepbound or Mounjaro. It may differ in formulation, purity, and potency.
Why you see such different prices online
If you have been comparing programs, you have noticed wide price variation. Here is why.
Hidden cost structures. Some programs advertise a low monthly price but bill lab work, provider visits, or a membership separately. Once those are added, the total can be much higher than the headline price.
Dose-based pricing. Some programs quote the starting-dose price. If the price rises as the dose increases, your monthly cost later in treatment can be higher.
Unclear what is included. When a website does not list what the monthly fee covers, ask before you assume it covers everything.
Programs without labs or monitoring. If a program offers tirzepatide without asking about your health history or offering follow-up with a licensed provider, ask how it monitors side effects. Ongoing provider oversight is part of using a prescription medication.
Prepay discounts. Some programs lower the per-month price if you pay for several months up front. Check the refund and cancellation terms before you prepay.
When evaluating any program, ask directly:
- Does the monthly price include medication, and at which dose?
- Does the price change as the dose increases?
- Does it include lab work?
- Does it include ongoing provider visits?
- Does it include coaching, shipping, and supplies?
- Are there membership fees, minimum commitments, or cancellation charges?
If a program will not answer these questions clearly, keep looking. For more on checking the pharmacy behind a program, see our guide on how to choose a safe compounding pharmacy.
Transformation Health does not accept payment from providers. How we make money.
How the process should work
Step 1: Health history
At most telehealth programs, you fill out a form covering your health history, current medications, and goals.
Step 2: Provider review
A licensed provider reviews your information and decides whether compounded tirzepatide is clinically appropriate for you.
Step 3: Pharmacy preparation
If a provider prescribes it, a state-licensed compounding pharmacy prepares the medication. Ask which pharmacy the program uses.
Step 4: Delivery and follow-up
The medication usually arrives by mail. A proper program includes follow-up with a licensed provider while you take it.
Eligibility
A licensed provider decides whether tirzepatide is appropriate based on your health history. Programs set their own criteria.
BMI criteria. Many programs use criteria similar to those in the brand-name tirzepatide trials. The SURMOUNT-1 trial, for example, enrolled adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, abnormal cholesterol, obstructive sleep apnea, or heart disease[4].
Health history. The provider will review your current medications, medical conditions, and any reasons GLP-1 medication may not be appropriate for you.
A provider may decide it is not appropriate. Even if your BMI meets a program’s threshold, a provider may decide tirzepatide is not right for your health situation.
How compounded tirzepatide works
Tirzepatide is a dual GIP and GLP-1 receptor agonist[2]. It activates two gut hormone pathways that together reduce appetite and slow the rate at which your stomach empties. For many people, that makes it easier to change eating habits. In the SURMOUNT-1 trial of brand-name tirzepatide, participants who took tirzepatide alongside lifestyle changes lost more weight on average than those who took a placebo[4]. Results vary, and trial results describe study participants, not what any individual will lose. Compounded tirzepatide was not studied in that trial.
Tirzepatide has risks as well as benefits. On the FDA label for brand-name tirzepatide (Zepbound), the most common side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, and indigestion. The label carries a boxed warning about thyroid C-cell tumors and says not to use tirzepatide if you or a family member has had medullary thyroid carcinoma or if you have Multiple Endocrine Neoplasia syndrome type 2[2]. Compounded tirzepatide has not been evaluated by the FDA, so label information describes the brand-name product studied.
Whether to continue, adjust, or stop the medication over time is a decision to make with your prescriber.
Injectable only
FDA-approved tirzepatide is available as an injection only[2][3]. Any oral tirzepatide a program offers is compounded and not FDA-approved. If you prefer an oral option, you can learn more about compounded semaglutide cost, including oral forms.
We're relaunching soon
We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.
Get StartedImportant disclosures
This content is for general education and is not medical advice. Talk with a licensed provider about your situation.
Compounded tirzepatide is not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed[5]. Compounded tirzepatide contains tirzepatide, but it is not the same as brand-name tirzepatide, which went through FDA review, and it may differ in formulation, purity, and potency. You cannot assume the two will produce the same results.
Regulatory status is subject to change. Compounding of tirzepatide depends on federal and state pharmacy law and on FDA policy, which has changed since FDA determined the tirzepatide shortage was resolved[1]. Availability cannot be guaranteed.
Results vary. Weight loss is not guaranteed and depends on many factors, including your starting weight, age, metabolism, adherence to the medication, eating habits, activity, stress, sleep, and overall health. Trial results describe study participants and are not a prediction for any individual.
Citations
[1] U.S. Food and Drug Administration. “FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.” Content current as of 04/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize (Accessed 2026-10-16.)
[2] U.S. Food and Drug Administration. ZEPBOUND (tirzepatide) injection, prescribing information, Boxed Warning and sections 1, 4, and 6. Revised 08/2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806Orig1s041correctedlbl.pdf
[3] U.S. Food and Drug Administration. MOUNJARO (tirzepatide) injection, prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215866Orig1s052lbl.pdf
[4] Jastreboff AM, Aronne LJ, Ahmad NN, et al. “Tirzepatide once weekly for the treatment of obesity.” NEJM. 2022. https://pubmed.ncbi.nlm.nih.gov/35658024/
[5] U.S. Food and Drug Administration. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” Content current as of 10/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss (Accessed 2026-10-16.)
Important: This content is for general education and is not medical advice. Talk with a licensed provider about your situation. Transformation Health is an independent GLP-1 guide. It does not provide medical care, prescribe, compound, or sell medication. A licensed provider decides whether a prescription is appropriate. Compounded tirzepatide is not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality. Compounded tirzepatide is not the same as brand-name products such as Zepbound or Mounjaro and may differ in formulation, purity, and potency. Results vary. Trial results describe study participants and are not a prediction for any individual. Availability of compounded tirzepatide depends on FDA policy and applicable state and federal pharmacy compounding laws, which may change. Zepbound and Mounjaro are trademarks of Eli Lilly and Company. Transformation Health is not affiliated with or endorsed by Eli Lilly and Company. Transformation Health does not accept payment from providers. How we make money.